Built for purpose driven individuals, online communities, programmers, artists and scientists who are collaboratively rewriting the way science is funded.
We propel open access to scientific R&D, turning key new pharmaceutical discoveries and medical devices into collective-commons.
ViralCure is part of the decentralized science movement that harnesses Web3 and blockchain technologies to address pain points, silos and bottlenecks in funding, publication and research.
ViralCure provides a regenerative approach to decentralized finance, to solve the systemic problems of an economic model that accumulates wealth at the expense of people and the planet.
We aim on establishing new ways of reviewing and supporting scientific researchers, in order to broad the horizon of projects being carried out. Propelling an open access to health-care. The outcome of these efforts must be affordable for all.
Establish a collaborative community of science supporters that can be rewarded through protocol incentives.
Offer a sustainable funding flow for Scientific Research.
Reach those who are now excluded from major institutional oversight.
The Scientific Advisory Commitee, or S.A.C, is ViralCure’s top-tier council of multidisciplinary leaders committed to supporting open science on a global scale.
The evolution of science has shown that we must build upon shared efforts to move discussions forward and bring innovation closer. We've got a track record of successful partnerships in the healthcare sector that have helped us meet our goals and collaborate with the most relevant researches of recent years.
raised in 2020
The greatest donation campaign for COVID19 in Brazil, during the pandemic. It raised +R30M for Hospital das Clinicas.
raised in 2021
GPS is born as the first ViralCure marketplace to finance Medical R&D through alternative methods.
ViralCure launched as an entity and platform for healthcare research and development supported by Web3 technology.
ViralCure goes live with its DApp and Marketplace features and Token IDO.
ViralCure supports the development of ImmunoX, a Biotechnology Start-up developing and applying immunotherapy solutions against cancer.